A detailed history of Golden State Equity Partners transactions in Zoetis Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 343 shares of ZTS stock, worth $60,697. This represents 0.04% of its overall portfolio holdings.

Number of Shares
343
Holding current value
$60,697
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$172.58 - $196.48 $59,194 - $67,392
343 New
343 $67,000
Q4 2023

Feb 02, 2024

BUY
$151.44 - $200.09 $176,427 - $233,104
1,165 New
1,165 $229,000
Q1 2021

May 13, 2021

SELL
$144.0 - $169.39 $272,880 - $320,994
-1,895 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$157.07 - $174.35 $297,647 - $330,393
1,895 New
1,895 $313,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.